Matthew L. Posard Nautilus Biotechnology, Inc. (NAUT) insider trading activity

NAUT Quotes by TradingView

Matthew L. Posard is Director of Nautilus Biotechnology, Inc.. Currently has a direct ownership of 50,000 shares of NAUT, which is worth approximately $88,000. The most recent transaction as insider was on Dec 01, 2021, when has been sold 30,000 shares (Common Stock) at a price of $4.47 per share, resulting in proceeds of $134,100. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 50K
0% 3M change
0% 12M change
Total Value Held $88,000

Matthew L. Posard Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 01 2021
BUY
Open market or private purchase
$134,100 $4.47 p/Share
30,000 Added 37.5%
50,000 Common Stock
Nov 30 2021
BUY
Open market or private purchase
$91,400 $4.57 p/Share
20,000 Added 50.0%
20,000 Common Stock

Also insider at

DMTK
DermTech, Inc. Healthcare
Director
TLIS
Talis Biomedical Corp Healthcare
Director
HALO
HALOZYME THERAPEUTICS, INC. Healthcare
MLP

Matthew L. Posard

Director
San Diego, CA

Track Institutional and Insider Activities on NAUT

Follow Nautilus Biotechnology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NAUT shares.

Notify only if

Insider Trading

Get notified when an Nautilus Biotechnology, Inc. insider buys or sells NAUT shares.

Notify only if

News

Receive news related to Nautilus Biotechnology, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NAUT